Labeler · US market

Eywa Pharma Inc

Eywa Pharma Inc is a US drug labeler with US FDA registrations covering 13 drug concepts (13 currently active) across 48 packages. It is currently the only active US supplier of 2 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes71930

Active drugs13

Registrations30 active / 30

Packages48

Sole supplier of2 drugs

Portfolio13 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Hydrocodone Bitartrate And Acetaminophen tablet	rx	6	12	SUPPLYING
Baclofen tablet	rx	3	9	SUPPLYING
Oxycodone And Acetaminophen tablet	rx	3	6	SUPPLYING
Acetaminophen And Codeine Phosphate tablet	rx	3	5	SUPPLYING
Hydrocortisone tablet	rx	3	3	SUPPLYING
Methylphenidate Hydrochloride solution	rx	2	2	SUPPLYING
Acetazolamide tablet	rx	2	2	SUPPLYING
Fludrocortisone Acetate tablet	rx	1	2	SUPPLYING
Oxycodone Hydrochloride solution	rx	2	2	SUPPLYING
Alosetron Hydrochloride tablet	rx	2	2	SUPPLYING
Hydrocodone Bitartrate And Acetaminophen solution	rx	1	1	SUPPLYING
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, syrup	rx	1	1	SUPPLYING
Quinidine Gluonate tablet, extended release	rx	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

At a glance

TypeLabeler
Labeler codes71930
Filing names1
Drugs (active)13
Drugs (all time)13
US registrations30
Packages48

Recent events

Shortages, recalls, and registration changes across all filing names.

Nov 10, 2020
RECALLRecall (Class II): Levetiracetam Tablets, USP 500 mg, packaged in 120-count bottle, Rx only, Manufactured by: VKT Pharma Private Limited S…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.